Results 221 to 230 of about 197,077 (309)
Some of the next articles are maybe not open access.
Food Chemistry, 2021
The inhibition of the α-amylase and α-glucosidase activity facilitates the maintenance of circulating glucose levels by decreasing the rate of blood sugar absorption.
Konstantinos Papoutsis +5 more
semanticscholar +1 more source
The inhibition of the α-amylase and α-glucosidase activity facilitates the maintenance of circulating glucose levels by decreasing the rate of blood sugar absorption.
Konstantinos Papoutsis +5 more
semanticscholar +1 more source
Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
Chemical Biology and Drug Design, 2021The alpha (α)‐amylase is a calcium metalloenzyme that aids digestion by breaking down polysaccharide molecules into smaller ones such as glucose and maltose. In addition, the enzyme causes postprandial hyperglycaemia and blood glucose levels to rise.
N. Kaur +5 more
semanticscholar +1 more source
Trends in Food Science and Technology, 2020
Background α-Amylase is a key enzyme of starch digestion, playing an important role in deciding glucose releasing amount. Inhibition of the enzyme activity by polyphenols is suggested as a potential approach in controlling starch digestion and regulating
Lijun Sun, Ming Miao
exaly +2 more sources
Background α-Amylase is a key enzyme of starch digestion, playing an important role in deciding glucose releasing amount. Inhibition of the enzyme activity by polyphenols is suggested as a potential approach in controlling starch digestion and regulating
Lijun Sun, Ming Miao
exaly +2 more sources
Critical reviews in food science and nutrition, 2021
Type 2 diabetes (T2D) is one of the most prevalent metabolic diseases worldwide and is characterized by increased postprandial hyperglycemia (PPHG). α-Amylase and α-glucosidase inhibitors have been shown to slow the release of glucose from starch and ...
C. Proença +3 more
semanticscholar +1 more source
Type 2 diabetes (T2D) is one of the most prevalent metabolic diseases worldwide and is characterized by increased postprandial hyperglycemia (PPHG). α-Amylase and α-glucosidase inhibitors have been shown to slow the release of glucose from starch and ...
C. Proença +3 more
semanticscholar +1 more source
Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, 2022
Inhibiting the activity of α-amylase has been considered an effective strategy to manage hyperglycemia. Hyperoside and quercetin are the main natural flavonoids in various plants, and the inhibition mechanism on α-amylase remains unclear.
Heyu Shen +7 more
semanticscholar +1 more source
Inhibiting the activity of α-amylase has been considered an effective strategy to manage hyperglycemia. Hyperoside and quercetin are the main natural flavonoids in various plants, and the inhibition mechanism on α-amylase remains unclear.
Heyu Shen +7 more
semanticscholar +1 more source

